Literature DB >> 10670912

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life.

B S Galer1, A Gianas, M P Jensen.   

Abstract

A prospective survey study was performed in patients with painful diabetic polyneuropathy (PDN) to assess the nature and scope of their pain. Pain associated with diabetic neuropathy is commonly encountered in clinical practice. Yet, little is known regarding the pain experience and impact on quality of life in persons with painful diabetic neuropathy. These 105 patients noted an average of 6/10 pain, most often described as 'burning', 'electric', 'sharp', and 'dull/ache', which, for most, is worse at night time and when tired or stressed. On average, patients reported that the pain caused substantial interference in sleep and enjoyment of life and moderate interference in recreational activities, normal work, mobility, general activity, social activities, and mood. Unexpectedly, a potential genetic predisposition to the development of painful neuropathy was suggested by the fact that a majority (56%) reported a family member with PDN. Thus, this study found that pain associated with diabetic neuropathy is a significant medical issue that has a substantial impact on the quality of life of many people with this condition.

Entities:  

Mesh:

Year:  2000        PMID: 10670912     DOI: 10.1016/s0168-8227(99)00112-6

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  131 in total

1.  The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

Authors:  Mélanie Drolet; Marc Brisson; Kenneth E Schmader; Myron J Levin; Robert Johnson; Michael N Oxman; David Patrick; Caty Blanchette; James A Mansi
Journal:  CMAJ       Date:  2010-10-04       Impact factor: 8.262

2.  The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.

Authors:  C J Currie; C D Poole; A Woehl; C Ll Morgan; S Cawley; M D Rousculp; M T Covington; J R Peters
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

3.  Management of painful diabetic neuropathy: what is new or in the pipeline for 2007?

Authors:  Dan Ziegler
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

4.  Pregabalin for painful diabetic peripheral neuropathy.

Authors:  Lee C Rogers; David G Armstrong
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-18

5.  Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus.

Authors:  Mohamad Adam Bujang; Mastura Ismail; Nur Khairul Bariyyah Mohd Hatta; Siti Haslina Othman; Nurakmal Baharum; Siti Sara Mat Lazim
Journal:  Malays J Med Sci       Date:  2017-08-18

6.  Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.

Authors:  Mark S Wallace; Thomas D Marcotte; Anya Umlauf; Ben Gouaux; Joseph H Atkinson
Journal:  J Pain       Date:  2015-04-03       Impact factor: 5.820

Review 7.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

8.  Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial.

Authors:  Muriel Viala-Danten; Susan Martin; Isabelle Guillemin; Ron D Hays
Journal:  Health Qual Life Outcomes       Date:  2008-12-17       Impact factor: 3.186

9.  Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.

Authors:  Dan Ziegler; Lusine Movsesyan; Boris Mankovsky; Irina Gurieva; Zhangentkhan Abylaiuly; Igor Strokov
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

Review 10.  Painful diabetic neuropathy: advantage of novel drugs over old drugs?

Authors:  Dan Ziegler
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.